CAJAL THERAPEUTICS Trademark
CAJAL THERAPEUTICS is a USPTO trademark filed by Cajal Therapeutics Inc.. Status: Pending.
Trademark Facts
| Mark | CAJAL THERAPEUTICS |
|---|---|
| Serial Number | 99222350 |
| Status | Pending |
| Filing Date | 2025-06-06 |
| Mark Type | Word |
| Nice Classes | 005 (Pharmaceuticals), 042 (Software & IT) |
| Owner | Cajal Therapeutics Inc. |
| Attorney of Record | Alyssa M. Worsham |
| Prosecution Events | 19 |
| Latest Event | EXRA on 2026-05-08 |
Goods & Services
Pharmaceutical preparations and substances for the treatment of viral, metabolic, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hematological, hepatological, ophthalmic, cardiometabolic, pulmonary, nephrological, respiratory, neurological, neuromuscular, gastrointestinal, hormonal, dermatological, psychiatric, and sexually transmitted diseases, conditions, and disorders.; Pharmaceutical research and development; drug discovery services; medical and scientific research.
Recent Prosecution Activity
| Date | Document | Type |
|---|---|---|
| 2026-02-24 | Notice of Allowance | ENA |
| 2025-12-30 | OG Publication Confirmation | PB3 |
| 2025-12-24 | Notification of Notice of Publication | EB4 |
| 2025-12-24 | Notice of Publication | PB1 |
| 2025-12-03 | TRAM Snapshot of App at Pub for Oppostn | PST |
| 2025-10-31 | Response to Office Action | ROA |
USPTO Refusals on Record
- disclaimer_required
- standard_loc